C4 Therapeutics, Inc. (CCCC)
$2.61-6.12%Close
SELLCRISIS · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $289M
- Beta
- 3.08
- P/E (TTM)
- -2.61
- Short % float
- 48.26%
- Days to cover
- 17.6
- SI change
- +0.5%
- 1W
- -7.45%
- 1M
- -23.91%
- vs SPY 1W
- -6.47%
- vs SPY 1M
- -25.77%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on CCCC?
- LOPJLB’s latest quantitative signal on C4 Therapeutics, Inc. (CCCC) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is CCCC in?
- C4 Therapeutics, Inc. (CCCC) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does C4 Therapeutics, Inc. (CCCC) do?
- C4 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapeutic candidates. Its core strategy involves degrading proteins implicated in disease, addressing a range of conditions including cancer, neurodegenerative disorders, and other illnesses. The company's primary drug candidate, CFT7455, is an orally administered MonoDAC degra…